New drug cocktail shows promise for Hard-to-Treat lymphoma
NCT ID NCT03533283
First seen Nov 01, 2025 · Last updated May 06, 2026 · Updated 24 times
Summary
This study tests a combination of three drugs (glofitamab, atezolizumab or polatuzumab vedotin, plus a pre-treatment of obinutuzumab) in adults with B-cell non-Hodgkin lymphoma that has come back or not responded to prior treatments. The goal is to find the safest dose and see if the drugs shrink tumors. About 211 participants will take part across multiple centers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-HODGKINS LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aarhus Universitetshospital Skejby
Aarhus N, 8200, Denmark
-
Asst Papa Giovanni Xxiii
Bergamo, Lombardy, 24127, Italy
-
Chaim Sheba Medical Center
Ramat Gan, 52621, Israel
-
Fond. IRCCS Istituto Nazionale Tumori
Milan, Lombardy, 20133, Italy
-
Hadassah Ein Karem Hospital
Jerusalem, 9112001, Israel
-
Hospital Clinico Universitario Virgen de la Victoria
Málaga, 29010, Spain
-
Hospital Clinico Universitario de Valencia
Valencia, 46010, Spain
-
Hospital Duran i Reynals
Barcelona, 08907, Spain
-
Hospital Universitari Vall d'Hebron
Barcelona, 08035, Spain
-
Istituto Nazionale Tumori Irccs Fondazione g. Pascale
Naples, Campania, 80131, Italy
-
Odense Universitetshospital
Odense C, 5000, Denmark
-
Policlinico S.Orsola-Malpighi
Bologna, Emilia-Romagna, 40138, Italy
-
Rabin Medical Center-Beilinson Campus
Petah Tikva, 4941492, Israel
-
Rigshospitalet
København Ø, 2100, Denmark
-
START Madrid-FJD, Hospital Fundacion Jimenez Diaz
Madrid, 28040, Spain
-
The HOPE Clinical Trials Unit
Leicester, LE1 5WW, United Kingdom
-
The Newcastle upon Tyne Hospitals NHS Foundation Trust
Newcastle upon Tyne, NE1 4LP, United Kingdom
-
UZ Gent
Ghent, 9000, Belgium
-
University College London Hospitals NHS Foundation Trust
London, W1T 7HA, United Kingdom
Conditions
Explore the condition pages connected to this study.